Barclays upgrades Givaudan stock rating to Equalweight on natural solutions growth

Published 08/07/2025, 09:02
Barclays upgrades Givaudan stock rating to Equalweight on natural solutions growth

Investing.com - Barclays (LON:BARC) has upgraded Givaudan SA (SIX:GIVN) stock rating from Underweight to Equalweight while raising its price target to CHF4,000.00 from CHF3,800.00.

The upgrade reflects Barclays’ increased optimism about Givaudan’s Taste & Wellness division’s top-line growth prospects over the next five years. The firm believes this growth could support a modest increase in the company’s mid-term growth targets, which Givaudan is scheduled to present on August 27.

Barclays identified Givaudan as one of the companies best positioned to capitalize on accelerated reformulation trends toward natural ingredient solutions in the U.S. market over the coming years, citing the breadth of its natural solutions portfolio, scale, and strong customer relationships.

Despite the upgrade, Barclays maintained a measured stance, noting that Givaudan’s premium valuation limits its enthusiasm for the stock. The firm also expressed concern that potential moderation in Fragrance division growth over the next five years could constrain margin expansion opportunities.

Givaudan, which trades in the U.S. as (OTC:GVDNY), is one of the world’s largest manufacturers of flavors, fragrances, and active cosmetic ingredients.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.